Antitrust Litigation - Pagina 11 di 15 - Fideres

Passing The Buck: When Damages End Up Elsewhere

Fideres explores the available economic methods used to estimate pass-on damages. We present two approaches that avoid common issues in

Dicembre 8, 2017

Fideres Consults On ANZ BBSW Benchmark Manipulation

Fideres was retained by Australia’s financial markets regulator Australian Securities and Investments Commission (ASIC) to provide financial expertise and develop

Novembre 10, 2017

Australian Gas: Are Further Market Troubles Ahead?

The Australian Competition and Consumer Commission (ACCC) has recently released two inquiry reports on the Eastern Australian Natural Gas Market.

Ottobre 17, 2017

CDOR Under Pressure: Canada’s Rate Benchmark In Trouble

Between September 2007 and September 2009, the Canadian Dollar Offered Rate (CDOR) was potentially suppressed by 30 – 50 basis

Ottobre 9, 2017

Generic Drug Prices: Why U.S. Costs Keep Rising

Generic drug price increases may be more widespread than the scope of any current lawsuit. Fideres has identified over 90

Gennaio 13, 2017

Fideres’s Generic Drugs Research Covered By Philadelphia Inquirer

The Philadelphia Inquirer recently covered Fideres's recent research on price increases of generic drugs as part of a full examination

Gennaio 10, 2017

Fideres Partners Supports Filing Of Econazole Price Fixing Class Action Against Major Generic Drug Manufacturers

Fideres Partners LLP, a leading independent economic consulting firm specializing in expert economic analysis for complex litigation, today announced its

Dicembre 30, 2016

Bloomberg Reports On Generic Drug Research By Fideres

Fideres’s research on generic drug pricing was covered today by Bloomberg. The research analysed price increases for individual generic drugs

Dicembre 22, 2016

Fideres Advises In Generic Drug Pricing Clobetasol Propionate Case

Fideres provided comprehensive consulting expert analysis in NECA IBEW Welfare Trust Fund v. Akorn Inc. (Case No. 1:16-cv-08109), part of

Ottobre 20, 2016

Twombly Or Not Twombly?

We assess the impact of the Twombly decision on US antitrust class actions. The number of filings has decreased, despite

Ottobre 7, 2016